MP
PRCT icon

Mangrove Partners’s Procept Biorobotics PRCT Stock Holding History

Mangrove Partners’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,223
Closed -$819K – 190
2024
Q3 		$819K Buy
+10,223
New +$726K 0.07% 120

Other funds holding PRCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Mangrove Partners's PRCT Position: Q4 2024 in Review

Mangrove Partners sold out of Procept Biorobotics (PRCT) in Q4 2024, closing a stake of 10,223 shares — an estimated $819K sold.

Mangrove Partners first reported a position in PRCT in Q3 2024 and held it in 1 quarter. The position peaked at $819K in Q3 2024. 281 funds tracked by Wall St. Rank hold PRCT as of Q4 2024.

  • Mangrove Partners reported no remaining Procept Biorobotics position as of Q4 2024 after selling out during the quarter.
  • Mangrove Partners sold 10,223 Procept Biorobotics shares in Q4 2024, an estimated $819K.
  • Mangrove Partners first reported a position in Procept Biorobotics in Q3 2024 and held it in 1 quarter.
  • Mangrove Partners's Procept Biorobotics position peaked at $819K in Q3 2024.
  • 281 funds tracked by Wall St. Rank held Procept Biorobotics as of Q4 2024.

Based on Mangrove Partners's 13F filing for Q4 2024, filed 14 Feb 2025.